SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000930413-19-003051
Filing Date
2019-12-18
Accepted
2019-12-18 12:40:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 c94767_sc13g.htm SC 13G 61497
2 c94767_ex1.htm EX-1 3959
  Complete submission text file 0000930413-19-003051.txt   67011
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Subject) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88005 | Film No.: 191291892
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

IRS No.: 010786483 | State of Incorp.: DE
Type: SC 13G